Sofia Dahlqvist

3.5k total citations · 3 hit papers
25 papers, 2.6k citations indexed

About

Sofia Dahlqvist is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Sofia Dahlqvist has authored 25 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 9 papers in Genetics. Recurrent topics in Sofia Dahlqvist's work include Diabetes Management and Research (20 papers), Diabetes Treatment and Management (16 papers) and Pancreatic function and diabetes (10 papers). Sofia Dahlqvist is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes Treatment and Management (16 papers) and Pancreatic function and diabetes (10 papers). Sofia Dahlqvist collaborates with scholars based in Sweden, United States and Finland. Sofia Dahlqvist's co-authors include Marcus Lind, Hans Wedel, Aldina Pivodic, Mikhail Kosiborod, Annika Rosengren, Ann‐Marie Svensson, Soffia Guðbjörnsdóttir, Mark A. Clements, Irl B. Hirsch and Mauro Tancredi and has published in prestigious journals such as New England Journal of Medicine, JAMA and Diabetes Care.

In The Last Decade

Sofia Dahlqvist

25 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excess Mortality among Persons with Type 2 Diabetes

2015 721 citations Mauro Tancredi, Annika Rosengren et al. New England Journal of Medicine profile →
Glycemic Control and Excess Mortality in Type 1 Diabetes

2014 673 citations Marcus Lind, Ann‐Marie Svensson et al. New England Journal of Medicine profile →
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

2017 529 citations Marcus Lind, William H. Polonsky et al. JAMA profile →

Peers

Countries citing papers authored by Sofia Dahlqvist

Since Specialization

Citations

This map shows the geographic impact of Sofia Dahlqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Dahlqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Dahlqvist more than expected).

Fields of papers citing papers by Sofia Dahlqvist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Dahlqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Dahlqvist. The network helps show where Sofia Dahlqvist may publish in the future.

Co-authorship network of co-authors of Sofia Dahlqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Dahlqvist. A scholar is included among the top collaborators of Sofia Dahlqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Dahlqvist. Sofia Dahlqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized Trial 2023 ·Journal of Diabetes Science and Technology ·(unknown), William H. Polonsky, Henrik Imberg, (unknown), Jarl Hellman, Magnus Wijkman, Jan Bolinder, (unknown), Sofia Dahlqvist, Thomas Nyström, (unknown), Irl B. Hirsch, Marcus Lind	2
2	Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections 2021 ·Diabetes Technology & Therapeutics ·(unknown), Irl B. Hirsch, Magnus Ekelund, (unknown), (unknown), Sofia Dahlqvist, Johan Svensson, Marcus Lind	3
3	Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections 2021 ·Journal of Diabetes and its Complications ·(unknown), Henrik Imberg, Magnus Wijkman, Irl B. Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Marcus Lind	2
4	The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4) 2020 ·Diabetes Care ·(unknown), (unknown), Aldina Pivodic, Arndís F. Ólafsdóttir, Sofia Dahlqvist, Irl B. Hirsch, Jarl Hellman, Magnus Ekelund, Tim Heise, William H. Polonsky, (unknown), Erik Schwarcz, Marcus Lind	40
5	Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections 2019 ·Diabetes Therapy ·(unknown), Henrik Imberg, Arndís F. Ólafsdóttir, Magnus Ekelund, Sofia Dahlqvist, Irl B. Hirsch, Karin Filipsson, Bo Åhrén, Stefan Sjöberg, Jaako Tuomilehto, Marcus Lind	16
6	Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI‐liraglutide study 5) 2018 ·Obesity Science & Practice ·(unknown), Karin Filipsson, (unknown), (unknown), Henrik Imberg, Stefan Sjöberg, Bo Åhrén, Sofia Dahlqvist, Thomas Gustafsson, Jaakko Tuomilehto, Irl B. Hirsch, Marcus Lind	12
7	Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes 2018 ·Journal of Clinical Hypertension ·Magnus Wijkman, (unknown), Sofia Dahlqvist, (unknown), Irl B. Hirsch, Jaakko Tuomilehto, Johan Mårtensson, Ole Torffvit, Henrik Imberg, (unknown), Marcus Lind	14
8	A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) 2018 ·Diabetes Technology & Therapeutics ·Arndís F. Ólafsdóttir, William H. Polonsky, Jan Bolinder, Irl B. Hirsch, Sofia Dahlqvist, Hans Wedel, Thomas Nyström, Magnus Wijkman, Erik Schwarcz, Jarl Hellman, Tim Heise, Marcus Lind	93
9	Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3) 2018 ·BMJ Open Diabetes Research & Care ·Sofia Dahlqvist, (unknown), Karin Filipsson, Thomas Gustafsson, Irl B. Hirsch, Jaakko Tuomilehto, Henrik Imberg, Bo Åhrén, Stig Attvall, Marcus Lind	19
10	Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections breakdown → 2017 ·JAMA ·Marcus Lind, William H. Polonsky, Irl B. Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, (unknown), Arndís F. Ólafsdóttir, Anders Frid, Hans Wedel, (unknown), Thomas Nyström, Jarl Hellman	529
11	Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study 2017 ·The Lancet Diabetes & Endocrinology ·Sofia Dahlqvist, Annika Rosengren, Soffia Guðbjörnsdóttir, Aldina Pivodic, Hans Wedel, Mikhail Kosiborod, Ann‐Marie Svensson, Marcus Lind	46
12	Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference 2016 ·Journal of Diabetes Science and Technology ·(unknown), Jort Kropff, (unknown), Jeffrey I. Joseph, Stig Attvall, Elvar Theodorsson, Irl B. Hirsch, Henrik Imberg, Sofia Dahlqvist, David C. Klonoff, Börje Haraldsson, J. Hans DeVries, Marcus Lind	21
13	Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study) 2016 ·Journal of Diabetes Science and Technology ·Marcus Lind, William H. Polonsky, Irl B. Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, (unknown), (unknown)	20
14	Excess Mortality among Persons with Type 2 Diabetes breakdown → 2015 ·New England Journal of Medicine ·Mauro Tancredi, Annika Rosengren, Ann‐Marie Svensson, Mikhail Kosiborod, Aldina Pivodic, Soffia Guðbjörnsdóttir, Hans Wedel, Mark A. Clements, Sofia Dahlqvist, Marcus Lind	721
15	Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial) 2015 ·BMJ ·Marcus Lind, Irl B. Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Bo Åhrén, Ole Torffvit, Stig Attvall, Magnus Ekelund, Karin Filipsson, (unknown), Stefan Sjöberg, (unknown)	60
16	A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes 2014 ·Diabetes Technology & Therapeutics ·(unknown), Jeffrey I. Joseph, (unknown), Irl B. Hirsch, Stig Attvall, Aldina Pivodic, Sofia Dahlqvist, David C. Klonoff, Börje Haraldsson, Marcus Lind	70
17	Glycemic Control and Excess Mortality in Type 1 Diabetes breakdown → 2014 ·New England Journal of Medicine ·Marcus Lind, Ann‐Marie Svensson, Mikhail Kosiborod, Soffia Guðbjörnsdóttir, Aldina Pivodic, Hans Wedel, Sofia Dahlqvist, Mark A. Clements, Annika Rosengren	673
18	Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial) 2014 ·Primary care diabetes ·Marcus Lind, Irl B. Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Ole Torffvit, (unknown)	10
19	Predicting the Effectiveness of Insulin Pump Therapy on Glycemic Control in Clinical Practice: A Retrospective Study of Patients with Type 1 Diabetes from 10 Outpatient Diabetes Clinics in Sweden over 5 Years 2014 ·Diabetes Technology & Therapeutics ·Mark A. Clements, (unknown), Stig Attvall, Magnus Ekelund, Aldina Pivodic, Sofia Dahlqvist, Martin Fahlén, Börje Haraldsson, Marcus Lind	19
20	Increased EMG Activity during Short Pauses in Patients with Primary Fibromyalgia 1989 ·Scandinavian Journal of Rheumatology ·Jessica Elert, Sofia Dahlqvist, Karin Henriksson-Larsén, Björn Gerdle	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact